Recurrent atrial flutter ablation and incidence of atrial fibrillation ablation after first-time ablation for typical atrial flutter: A nation-wide Danish cohort study.

[1]  C. Blomström-Lundqvist,et al.  A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes , 2018, European heart journal.

[2]  J. Andreasen,et al.  Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study , 2018, Journal of Cardiothoracic Surgery.

[3]  C. Torp‐Pedersen,et al.  Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study , 2018, Europace.

[4]  S. Riahi,et al.  P4823Prognostic differences after ablation for atrial flutter compared to atrial fibrillation using a multistate transition model: a nationwide cohort study , 2018, European Heart Journal.

[5]  A. Skanes,et al.  Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter-A Population-Based Study. , 2018, The Canadian journal of cardiology.

[6]  E. Schmidt,et al.  Marine n-3 PUFA, heart rate variability and ventricular arrhythmias in patients on chronic dialysis: a cross-sectional study , 2018, British Journal of Nutrition.

[7]  C. Sticherling,et al.  Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Ronald Jones,et al.  Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study. , 2017, Heart rhythm.

[9]  P. Hoff,et al.  Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter , 2017, Scandinavian cardiovascular journal : SCJ.

[10]  F. Cosío,et al.  European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[12]  John M. Miller,et al.  Incidence of Atrial Fibrillation After Atrial Flutter Ablation. , 2016, JACC. Clinical electrophysiology.

[13]  J. Andrade,et al.  Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  L. Friberg,et al.  Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. , 2016, European heart journal.

[15]  R. Bai,et al.  HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. , 2015, Heart rhythm.

[16]  A. Glass,et al.  Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation Ablation in Atrial Flutter (Triple A) trial. , 2015, Heart rhythm.

[17]  S. Adabag,et al.  Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter. , 2014, Heart rhythm.

[18]  R. Shaw,et al.  Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: the PReVENT AF Study I. , 2014, Heart rhythm.

[19]  S. Riahi,et al.  Groin hematoma after electrophysiological procedures—incidence and predisposing factors , 2014, Scandinavian cardiovascular journal : SCJ.

[20]  J. Struijk,et al.  Long Pacing Pulses Reduce Phrenic Nerve Stimulation in Left Ventricular Pacing , 2014, Journal of cardiovascular electrophysiology.

[21]  L. Oddershede,et al.  The effect of radiotherapy beam energy on modern cardiac devices: an in vitro study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  A. Tjønneland,et al.  A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  J. Seara,et al.  Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter , 2014, Clinical Research in Cardiology.

[24]  F. Skjøth,et al.  Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  S. Pehrson,et al.  Radiofrekvensablation af atrieflimren , 2013 .

[26]  P. Weeke,et al.  Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  E. Schmidt,et al.  No effect of high-dose atorvastatin on leukotriene B₄ formation from neutrophils in patients treated with coronary bypass surgery: a randomized placebo-controlled double-blinded trial with a crossover design. , 2012, Prostaglandins, leukotrienes, and essential fatty acids.

[28]  Prashanthan Sanders,et al.  Catheter ablation of atrial arrhythmias: state of the art , 2012, The Lancet.

[29]  W. Toff,et al.  Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  K. Overvad,et al.  Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry , 2012, Scandinavian cardiovascular journal : SCJ.

[31]  W. Toff,et al.  Abstract 10994: Heart Failure in Patients with Sick Sinus Syndrome Treated with Single And Dual Chamber Pacing - No Association with Pacing Mode or Right Ventricular Pacing Site , 2011 .

[32]  Vibeke Høgh,et al.  Abstract P136: Assessing the Impact of Atrial Fibrillation Symptoms: Whose Perspective Should Be Used to Develop a Health Status Questionnaire? , 2011, Circulation: Cardiovascular Quality and Outcomes.

[33]  S. Pedersen,et al.  Attitudes towards implantable cardioverter-defibrillator therapy: a national survey in Danish health-care professionals. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  M. Galvani,et al.  Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up , 2011, Journal of cardiovascular medicine.

[35]  S. Riahi,et al.  High-dose radiotherapy exposure to cardiac pacemakers may be safe in selected patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  K. Ellenbogen,et al.  Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis , 2009, Circulation. Arrhythmia and electrophysiology.

[37]  J. Daubert,et al.  Acute and long-term efficacy and safety of catheter cryoablation of the cavotricuspid isthmus for treatment of type 1 atrial flutter. , 2008, Heart rhythm.

[38]  E. Toft,et al.  The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery. , 2006, International journal of cardiology.

[39]  E. Toft,et al.  Statins, Ventricular Arrhythmias and Heart Rate Variability in Patients with Implantable Cardioverter Defibrillators and Coronary Heart Disease , 2005, Cardiology.

[40]  E. Toft,et al.  Heart rate variability is associated with haptoglobin phenotype in patients with coronary artery disease , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[41]  C. Tita,et al.  Recurrence rate of atrial flutter after initial presentation in patients on drug treatment. , 2003, The American journal of cardiology.

[42]  P. Neužil,et al.  Wireless LV endocardial stimulation for CRT: Primary results of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study , 2015 .

[43]  G. Gislason,et al.  The impact of chronic renal disease on short- and long-term survival and risk of appropriate ICD therapy in primary prevention ICD/CRT-D patients , 2015 .

[44]  M. B. Jensen,et al.  The use of a Handheld ECG Monitor to detect atrial fibrillation in General Practice , 2015 .

[45]  D. Theuns,et al.  Performance of fluoroscopy for diagnosing conductor externalization in recalled St. Jude Medical Riata defibrillator leads , 2013 .

[46]  K. Overvad,et al.  Moderate consumption of marine n-3 fatty acids is associated with a lower risk of atrial fibrillation - a Danish cohort study , 2013 .

[47]  D. Theuns,et al.  Location and degree of conductor externalization in recalled St. Jude Medical Riata defibrillator leads: results of a nation-wide fluoroscopic screening , 2013 .

[48]  J. Andreasen,et al.  Atrial fibrillation: Ablation or surgical treatment II: Fast II. A randomized study comparing non-pharmacologic therapy in patients with drug-refractory atrial fibrillation referred for a first time invasive treatment. , 2012 .

[49]  E. Toft,et al.  The effect of atorvastatin on formation of leukotriene B4 in patients with coronary artery disease , 2012 .

[50]  J. Andreasen,et al.  Atrial fibrillation: Ablation or surgical treatment II: Fast II. , 2012 .

[51]  E. Schmidt,et al.  Soluble cellular adhesion molecules and c-reactive protein in patients with intra-cardiac defibrillator: relation to arrhytmic events and heart rate variability , 2007 .

[52]  S. Riahi.  HMG-CoA reductase inhibitors and heart rate variability , 2005 .